TNFRSF12A and prostate carcinoma: More-over, TWEAK/Fn14 activates non-canonic NF-κB signals, but it does reveal two distinct findings for melanoma and prostate cancer cells, which are cell invasiveness prevention and stimulation (Liu et al., 2019[8]).